Ludwig, Jens; Marcotte, Dave E. - In: Journal of Policy Analysis and Management 24 (2005) 2, pp. 249-272
Policymakers are increasingly concerned that a relatively new class of anti-depressant drugs, selective serotonin re-uptake inhibitors (SSRI), may increase the risk of suicide for at least some patients, particularly children. Prior randomized trials are not informative on this question because...